In ACPA‐negative RA patients (n = 48), there were more autoantibody‐positive patients in early stage (ranging from 21.7 to 46.2%; Figure 4B) than in the established stage (ranging from 8.7 to 21.7%; Figure 4B). The gene discussed is PRTN3; the disease is rheumatoid arthritis.